This partnership aims to provide a new frontier in cancer care and vascular malformation treatment, offering clinicians cutting-edge technology to improve patient outcomes. SYDNEY, Nov. 18, 2024 ...

Good afternoon, ladies and gentlemen, and welcome to the Perimeter Medical Q3 2024 Conference Call. At this time, all lines are in listen-only mode. [Operator Instructions]. This call is being ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Ladies and gentlemen, greetings, and welcome to the KORU Medical ...

Otsuka’s IV solutions subsidiary, Otsuka Pharmaceutical Factory, is breaking into the North American market with the help of ...

Nihon Kohden, a global leader in medical device innovation for high-precision patient monitoring and diagnostics, has ...

ICU Medical ( (ICUI) ) has released its Q3 earnings. Here is a breakdown of the information ICU Medical presented to its investors. ICU ...

Recent quality and operational issues at Smiths, which originated before it was purchased, greatly reduced ICU’s gross margin after the acquisition. These issues have required additional spending to ...

Q3 2024 Earnings Conference Call November 12, 2024 4:30 PM ETCompany ParticipantsJohn Mills - ICRVivek Jain - Chief ...

OPF’s history of innovation and consistent investment in state-of-the-art IV solutions manufacturing technologies combined with ICU Medical’s differentiated IV pumps and consumables will create a ...